ABBVIE INC.
Symbol: ABBV (NYSE)
206.10
▲ (0.69%) 1.420
Company Description:
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Key Stats
- Today's Open: $205.91
- Today's High: $206.808
- Today's Low: $204.371
- Today's Volume: 4.43M
- Yesterday Close: $204.68
- Yesterday High: $205.06
- Yesterday Low: $200.86
- Yesterday Volume: 4.64M
- Last Min Volume: 1
- Last Min High: $206.1
- Last Min Low: $206.1
- Last Min VWAP: $206.1
Company Profile
- Name: ABBVIE INC.
- Website: https://www.abbvie.com
- Listed Date: 2012-12-10
- Location: NORTH CHICAGO, IL
- Market Status: Active
- CIK Number: 0001551152
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $365.13B
- Round Lot: 100
- Outstanding Shares: 1.77B
- Asset Type: CS
RECENT FILINGS FOR ABBV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 4 | View |
| 2025-08-12 | 144 | View |
| 2025-08-08 | 144 | View |
| 2025-08-07 | 4 | View |
| 2025-08-05 | 144 | View |
| 2025-08-04 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-07-30 | 3/A | View |
| 2025-07-11 | 3 | View |
| 2025-07-07 | SCHEDULE 13G/A | View |
| 2025-07-03 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-13 | 11-K | View |
| 2025-05-30 | SD | View |
| 2025-05-13 | 4 | View |
| 2025-05-13 | 4 | View |
| 2025-05-13 | 4 | View |
| 2025-05-13 | 4 | View |
Latest News on ABBV